Stephanie Kong
Overview
Explore the profile of Stephanie Kong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nadel J, Giannotti N, Kong S, Ugander M, Jabbour A, Stocker R
J Cardiovasc Comput Tomogr
. 2023 Apr;
17(5):358-360.
PMID: 37032220
No abstract available.
2.
Kong S, Moharil P, Handly-Santana A, Boehnke N, Panayiotou R, Gomerdinger V, et al.
Bioeng Transl Med
. 2023 Mar;
8(2):e10429.
PMID: 36925689
The majority of patients with high grade serous ovarian cancer (HGSOC) develop recurrent disease and chemotherapy resistance. To identify drug combinations that would be effective in treatment of chemotherapy resistant...
3.
Patch testing results in adult patients with dermatitis during the coronavirus disease 2019 pandemic
Kong S, Mawhirt S
Ann Allergy Asthma Immunol
. 2022 Jul;
129(4):521-522.
PMID: 35858656
No abstract available.
4.
Choi K, Correa S, Min J, Li J, Roy S, Laccetti K, et al.
Adv Funct Mater
. 2019 Dec;
29(20).
PMID: 31839764
Using siRNA therapeutics to treat hematologic malignancies has been unsuccessful because blood cancer cells exhibit remarkable resistance to standard transfection methods. Herein we report the successful delivery of siRNA therapeutics...
5.
Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir
Liu R, Curry S, McMonagle P, Yeh W, Ludmerer S, Jumes P, et al.
Antimicrob Agents Chemother
. 2015 Aug;
59(11):6922-9.
PMID: 26303801
Elbasvir is an investigational NS5A inhibitor with in vitro activity against multiple HCV genotypes. Antiviral activity of elbasvir was measured in replicons derived from wild-type or resistant variants of genotypes...
6.
Fraser S, Midwinter R, Coupland L, Kong S, Berger B, Yeo J, et al.
Haematologica
. 2015 Feb;
100(5):601-10.
PMID: 25682599
Heme oxygenase-1 is critical for iron recycling during red blood cell turnover, whereas its impact on steady-state erythropoiesis and red blood cell lifespan is not known. We show here that...
7.
Mulvey C, Ferguson J, Tabita-Martinez J, Kong S, Shah R, Patel P, et al.
J Am Heart Assoc
. 2012 Nov;
1(4):e002923.
PMID: 23130172
Background: Data conflict with regard to whether peroxisome proliferator-activated receptor-α agonism suppresses inflammation in humans. We hypothesized that in healthy adults peroxisome proliferator-activated receptor-α agonism with fenofibrate would blunt the...
8.
Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, et al.
Proc Natl Acad Sci U S A
. 2007 Aug;
104(36):14501-6.
PMID: 17675407
Here, we report generation and characterization of Disrupted-In-Schizophrenia-1 (DISC1) genetically engineered mice as a potential model for major mental illnesses, such as schizophrenia. DISC1 is a promising genetic risk factor...
9.
Gerber M, Eissenberg J, Kong S, Tenney K, Conaway J, Conaway R, et al.
Mol Cell Biol
. 2004 Oct;
24(22):9911-9.
PMID: 15509793
A number of transcription factors that increase the catalytic rate of mRNA synthesis by RNA polymerase II (Pol II) have been purified from higher eukaryotes. Among these are the ELL...